Home › Calculator › TVTX Dividend Calculator 2026
TVTX Dividend Calculator 2026
No dividendHealthcareTravere Therapeutics, Inc. · NASDAQ
Price: $50.08 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
TVTX is not a dividend-focused stock
TVTX pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
TVTX Dividend Yield
Travere Therapeutics, Inc. (TVTX) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When TVTX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Travere Therapeutics, Inc. (TVTX) — Dividend Analysis 2026
Travere Therapeutics, Inc. is a biopharmaceutical company developing therapies for rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral, once-daily, non-immunosuppressive medication targeting two pathways of disease progression (endothelin-1 and angiotensin-II). Sparsentan received accelerated FDA approval in February 2023 and full approval in September 2024 to slow kidney function decline in adults with primary IgA nephropathy (IgAN) at risk of progression. In April 2026, the FDA approved FILSPARI to reduce proteinuria in adult and pediatric patients aged 8 and older with focal segmental glomerulosclerosis (FSGS) without nephrotic syndrome, making it the first and only FDA-approved medicine for FSGS. The company also markets Thiola and Thiola EC (tiopronin tablets) for cystinuria, a rare genetic disorder causing recurring kidney stones. Its pipeline includes pegtibatinase, an investigational enzyme replacement therapy for classical homocystinuria (HCU). Formerly Retrophin, Inc. (renamed November 2020), Travere is headquartered in San Diego, California, and incorporated in Delaware.
TVTX Dividend & DRIP — Frequently Asked Questions
Does TVTX pay a dividend?
No. Travere Therapeutics, Inc. (TVTX) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of TVTX?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does TVTX have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. TVTX has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to TVTX
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full TVTX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TVTX position with:
🌍 TVTX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold TVTX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 TVTX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 TVTX Dividend Payment Schedule
TVTX pays quarterly — 4 times per year. Ex-div: —.
📊 TVTX vs Healthcare Benchmarks
How TVTX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TVTX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ TVTX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-10-15 | 200,000 | $8.93 | $1.79M | ||
| Sale | 2026-10-15 | 128,065 | $52.97 | $6.78M | ||
| Sale | 2026-10-15 | 37,270 | $54.20 | $2.02M | ||
| M-Exempt | 2026-10-15 | 43,735 | $26.88 | $1.18M | ||
| Sale | 2026-10-15 | 78,400 | $55.02 | $4.31M | ||
| M-Exempt | 2026-10-15 | 43,735 | $26.88 | $1.18M | ||
| M-Exempt | 2026-10-15 | 200,000 | $8.93 | $1.79M | ||
| M-Exempt | 2026-09-16 | 57,500 | $26.88 | $1.55M | ||
| M-Exempt | 2026-09-15 | 39,650 | $17.96 | $712.1K | ||
| M-Exempt | 2026-09-15 | 39,000 | $25.25 | $984.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare TVTX with peers: TVTX vs AAPG · TVTX vs APGE · TVTX vs CELC
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TVTX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Travere Therapeutics, Inc. (TVTX) is currently trading at $50.08, 27% below its 52-week high. It does not currently pay a regular dividend.
Does TVTX Pay a Dividend? Travere Therapeutics, Inc. Dividend Status
Travere Therapeutics, Inc. (TVTX) is a healthcare stock trading at $50.08. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest TVTX News
LiveProjected your TVTX DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.